Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Healthpeak Properties, Inc.
DOC
NYSE·Real Estate·REIT - Healthcare Facilities·Mkt cap $14.9B
$21.89
▲ +1.16%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$15.70 - $21.98
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 18.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Strategic Property Portfolio
- Healthcare Sector Expertise
- High-Quality Asset Selection
- Proven REIT Management Team
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Aging Population Trends
Value
Significant premium - growth priced in
Momentum
Hot
+31.0% over 3m
Quality
Thin
Strong fundamentals
Dividend
High yield
5.64% yield
Smart-money signal
Who's buying DOC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 22, 2026
MAY 5, 2026
Reported EPS of $0.28 vs $0.05 consensus (+430.7% surprise). Revenue of $738.8M vs $694.6M expected (+6.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+430.7%
Next: Apr 22, 2026
Revenue trend · last 8Q
—
—
+26%
+16%
-0%
+1%
+3%
+7%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$695.5M
$700.4M
$698.0M
$702.9M
$694.3M
$705.9M
$719.4M
$753.0M
Margins · last 8Q
Gross
—
Operating
—
Profit
25.7%
Wall Street consensus
10 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
$19.00
▼ -13.2% vs $21.89
Latest: BMO Capital · Jun 15, 2026
3 analysts covering